N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): A new, potent vasodilator
- 1 April 1980
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 36 (4) , 445-447
- https://doi.org/10.1007/bf01975139
Abstract
N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134) is a new agent which induces a marked and sustained hypotensive response in normotensive and renal, neurogenic, and spontaneously hypertensive rats, as well as in normotensive and renal hypertensive dogs. The overall potency of this compound is 2–3 times greater than that of hydralazine. The fall of blood pressure is accompanied by an increase in heart rate and cardiac output and a decrease in total peripheral resistance. The hypotensive effect appears to be due primarily to a direct relaxant effect on vascular smooth muscle.This publication has 14 references indexed in Scilit:
- Synthesis and hypotensive activity of N-alkyl-N''-cyano-N'-pyridylguanidinesJournal of Medicinal Chemistry, 1978
- Proceedings: Antihypertensive activity of a new 3-hydrazinopyridazine derivative: ISF 2123.1974
- Vasodilator drugs in the treatment of hypertension.1974
- Vasodilator Drugs in the Treatment of HypertensionArchives of internal medicine (1960), 1974
- Measurement of blood flow by thermodilutionThe American Journal of Cardiology, 1972
- Application of a Radioimmunoassay for Angiotensin I to the Physiologic Measurements of Plasma Renin Activity in Normal Human Subjects1Journal of Clinical Endocrinology & Metabolism, 1969
- Neurogenic Hypertension in the RatCirculation Research, 1964
- Eine neue Gruppe blutdrucksenkender Substanzen von besonderem WirkungscharakterCellular and Molecular Life Sciences, 1950
- A Simplified Procedure for Inducing Chronic Renal Hypertension in the Mammal.Experimental Biology and Medicine, 1944
- STUDIES ON EXPERIMENTAL HYPERTENSIONThe Journal of Experimental Medicine, 1934